vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $69.8M, roughly 1.5× RIGEL PHARMACEUTICALS INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 11.6%, a 372.4% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs 8.0%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 1.0%).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

CSV vs RIGL — Head-to-Head

Bigger by revenue
CSV
CSV
1.5× larger
CSV
$105.5M
$69.8M
RIGL
Growing faster (revenue YoY)
RIGL
RIGL
+13.2% gap
RIGL
21.2%
8.0%
CSV
Higher net margin
RIGL
RIGL
372.4% more per $
RIGL
384.0%
11.6%
CSV
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
1.0%
CSV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
RIGL
RIGL
Revenue
$105.5M
$69.8M
Net Profit
$12.3M
$268.1M
Gross Margin
34.8%
91.5%
Operating Margin
23.3%
33.2%
Net Margin
11.6%
384.0%
Revenue YoY
8.0%
21.2%
Net Profit YoY
24.5%
1769.2%
EPS (diluted)
$0.76
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
RIGL
RIGL
Q4 25
$105.5M
$69.8M
Q3 25
$102.7M
$69.5M
Q2 25
$102.1M
$101.7M
Q1 25
$107.1M
$53.3M
Q4 24
$97.7M
$57.6M
Q3 24
$100.7M
$55.3M
Q2 24
$102.3M
$36.8M
Q1 24
$103.5M
$29.5M
Net Profit
CSV
CSV
RIGL
RIGL
Q4 25
$12.3M
$268.1M
Q3 25
$6.6M
$27.9M
Q2 25
$11.7M
$59.6M
Q1 25
$20.9M
$11.4M
Q4 24
$9.9M
$14.3M
Q3 24
$9.9M
$12.4M
Q2 24
$6.3M
$-1.0M
Q1 24
$7.0M
$-8.2M
Gross Margin
CSV
CSV
RIGL
RIGL
Q4 25
34.8%
91.5%
Q3 25
35.3%
93.2%
Q2 25
35.2%
95.6%
Q1 25
35.3%
91.7%
Q4 24
34.4%
89.9%
Q3 24
35.2%
85.5%
Q2 24
36.2%
92.4%
Q1 24
36.0%
93.1%
Operating Margin
CSV
CSV
RIGL
RIGL
Q4 25
23.3%
33.2%
Q3 25
17.0%
40.9%
Q2 25
23.5%
60.1%
Q1 25
29.5%
23.9%
Q4 24
21.6%
28.9%
Q3 24
22.7%
25.4%
Q2 24
18.0%
1.2%
Q1 24
18.8%
-23.6%
Net Margin
CSV
CSV
RIGL
RIGL
Q4 25
11.6%
384.0%
Q3 25
6.4%
40.2%
Q2 25
11.5%
58.6%
Q1 25
19.5%
21.5%
Q4 24
10.1%
24.9%
Q3 24
9.8%
22.5%
Q2 24
6.1%
-2.8%
Q1 24
6.7%
-27.9%
EPS (diluted)
CSV
CSV
RIGL
RIGL
Q4 25
$0.76
$14.11
Q3 25
$0.41
$1.46
Q2 25
$0.74
$3.28
Q1 25
$1.34
$0.63
Q4 24
$0.62
$0.82
Q3 24
$0.63
$0.70
Q2 24
$0.40
$-0.06
Q1 24
$0.45
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$1.7M
$155.0M
Total DebtLower is stronger
$52.5M
Stockholders' EquityBook value
$254.8M
$391.5M
Total Assets
$1.3B
$513.6M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
RIGL
RIGL
Q4 25
$1.7M
$155.0M
Q3 25
$1.2M
$137.1M
Q2 25
$1.4M
$108.4M
Q1 25
$4.6M
$77.1M
Q4 24
$1.2M
$77.3M
Q3 24
$1.3M
$61.1M
Q2 24
$1.5M
$49.1M
Q1 24
$1.7M
$49.5M
Total Debt
CSV
CSV
RIGL
RIGL
Q4 25
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
CSV
CSV
RIGL
RIGL
Q4 25
$254.8M
$391.5M
Q3 25
$242.1M
$117.6M
Q2 25
$235.4M
$81.9M
Q1 25
$223.1M
$18.6M
Q4 24
$208.6M
$3.3M
Q3 24
$198.1M
$-14.6M
Q2 24
$187.9M
$-29.9M
Q1 24
$179.6M
$-31.7M
Total Assets
CSV
CSV
RIGL
RIGL
Q4 25
$1.3B
$513.6M
Q3 25
$1.3B
$242.5M
Q2 25
$1.3B
$206.7M
Q1 25
$1.3B
$176.0M
Q4 24
$1.3B
$164.0M
Q3 24
$1.3B
$139.4M
Q2 24
$1.3B
$128.4M
Q1 24
$1.3B
$126.5M
Debt / Equity
CSV
CSV
RIGL
RIGL
Q4 25
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
RIGL
RIGL
Operating Cash FlowLast quarter
$14.1M
$22.0M
Free Cash FlowOCF − Capex
$6.2M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
7.5%
Cash ConversionOCF / Net Profit
1.15×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
RIGL
RIGL
Q4 25
$14.1M
$22.0M
Q3 25
$24.7M
$24.0M
Q2 25
$8.1M
$30.5M
Q1 25
$13.8M
$-893.0K
Q4 24
$9.3M
$14.5M
Q3 24
$20.9M
$21.7M
Q2 24
$2.2M
$302.0K
Q1 24
$19.7M
$-5.0M
Free Cash Flow
CSV
CSV
RIGL
RIGL
Q4 25
$6.2M
Q3 25
$18.0M
Q2 25
$5.2M
Q1 25
$10.6M
Q4 24
$4.9M
Q3 24
$16.2M
Q2 24
$-1.4M
Q1 24
$16.2M
FCF Margin
CSV
CSV
RIGL
RIGL
Q4 25
5.9%
Q3 25
17.5%
Q2 25
5.1%
Q1 25
9.9%
Q4 24
5.0%
Q3 24
16.1%
Q2 24
-1.4%
Q1 24
15.6%
Capex Intensity
CSV
CSV
RIGL
RIGL
Q4 25
7.5%
Q3 25
6.5%
Q2 25
2.8%
Q1 25
3.0%
Q4 24
4.5%
Q3 24
4.6%
Q2 24
3.5%
Q1 24
3.4%
Cash Conversion
CSV
CSV
RIGL
RIGL
Q4 25
1.15×
0.08×
Q3 25
3.76×
0.86×
Q2 25
0.69×
0.51×
Q1 25
0.66×
-0.08×
Q4 24
0.94×
1.01×
Q3 24
2.11×
1.75×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons